Breast Lesion Localization Methods Market Trends and Alternative Techniques Demand Forecast for 2024

Global Breast Lesion Localization Methods Market: Overview

According to the World Cancer Research Fund International, breast cancer is the most common cancer in women, with an estimated 1.7 million new cases diagnosed in 2012. The highest incidence of breast cancer was in North America and Oceania, with Belgium, Denmark, and France reporting the highest rate of breast cancer. The incidence rate of this cancer in North America was an estimated 80 per 100,000 individuals in Canada and around 92 per 100,000 in the U.S.

Get Exclusive Report Brochure with Industry Insight:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12656

This alarming rise in the incidence of breast cancer has resulted in growing awareness about the disease among women and rise in the number of screening and imaging techniques in the market. Early detection of the benign or malignant characteristics of palpable and non-palpable breast lesions can result in effective and timely treatment of various breast abnormalities. This is one of the major factors driving the global breast lesion localization methods market.

The report on the breast lesion localization methods market evaluates the overall performance of the global market and determines the various driving forces fueling growth over the years. The key challenges that lie ahead and recommendations by industry experts have also been included to give clients a well-rounded assessment of the breast lesion localization methods market.

Global Breast Lesion Localization Methods Market: Trends and Opportunities

Limitations of conventional localization methods as identified by end-users (surgeons) have increased the need for alternative techniques of breast lesion localization. Technical challenges and drawbacks pertaining to excision and same-day wire placement have led to the development of advanced breast lesion localization methods. This has driven the global market. Favorable reimbursement scenario in several developed countries, increase in the number of breast cancer surgeries, and ongoing research in the field have also contributed to the growth of the breast lesion localization methods market.

However, regulatory approval procedures are immensely lengthy and complex due to the risks associated with several breast lesion localization devices. This is likely to hamper the growth of the global market.

Global Breast Lesion Localization Methods Market: Treatment Outlook

The most widely used breast lesion localization methods include wire-guided localization (WGL), magnetic tracers, electromagnetic reflectors, and radioisotope localization methods such as radio-guided occult lesion localization (ROLL) and radioactive seed localization (RSL). WGL involves insertion of a wire to the center of the lesion. The ROLL method is a new technique of the localization and removal of non-palpable lesions. It involves intratumoral insertion of a radioactive tracer. In the RSL technique, an iodine seed is implanted in the center of the tumor.

There have been several studies and trials comparing and reviewing the effectiveness of various breast lesion localization methods. Cochrane conducted one of these in March 2015. Cochrane is an England-based non-profit, non-governmental firm dedicated to medical research and reviews. The organization studied the performance of wire-guided localization, the most widely used approach for the surgical removal of non-palpable breast lesions, against modern alternatives such as ROLL and RSL.

The study found that people who opted for ROLL and WGL treatment presented similar results in the successful localization and removal of the lump. The post-operative complication rates of both methods were also similar. Compared to WGL, ROLL treatment had lower re-intervention rates and resulted in slightly fewer positive tumor margins. In terms of successful location of the lesion, WGL was found to be superior to RSL. However, as far as the successful removal of the lump is concerned, both techniques were found to be equally effective. Compared to WGL, RSL resulted in fewer positive tumor margins.

The results of the Cochrane study revealed that WGL continues to be a safe and tested breast lesion localization method, considering the effectiveness of new alternatives over this technique is not statistically significant. At the same time, RSL and ROLL are equally reliable and can be offered to patients as a comparable replacement for WGL.

Browse Full Report@ http://www.transparencymarketresearch.com/breast-lesion-localization-methods-market.html

About Company:
Transparency Market Research is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.